416 related articles for article (PubMed ID: 28191765)
41. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
43. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
44. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
[TBL] [Abstract][Full Text] [Related]
45. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
46. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
47. Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Cell Commun Signal; 2018 Apr; 16(1):13. PubMed ID: 29625612
[TBL] [Abstract][Full Text] [Related]
48. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
49. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
[TBL] [Abstract][Full Text] [Related]
50. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis.
Piek E; Sleumer LS; van Someren EP; Heuver L; de Haan JR; de Grijs I; Gilissen C; Hendriks JM; van Ravestein-van Os RI; Bauerschmidt S; Dechering KJ; van Zoelen EJ
Bone; 2010 Mar; 46(3):613-27. PubMed ID: 19857615
[TBL] [Abstract][Full Text] [Related]
51. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
Li H; Han X; Yang S; Wang Y; Dong Y; Tang T
Oncogene; 2021 Apr; 40(15):2785-2802. PubMed ID: 33716296
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.
Mannerström B; Kornilov R; Abu-Shahba AG; Chowdhury IM; Sinha S; Seppänen-Kaijansinkko R; Kaur S
Epigenetics; 2019 Apr; 14(4):352-364. PubMed ID: 30907225
[TBL] [Abstract][Full Text] [Related]
53. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation.
Li Z; Meng D; Liu Y; Bi F; Tian K; Xu J; Sun J; Gu C; Li Y
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23537. PubMed ID: 37700640
[TBL] [Abstract][Full Text] [Related]
55. Liver tumor formation by a mutant retinoblastoma protein in the transgenic mice is caused by an upregulation of c-Myc target genes.
Wang B; Hikosaka K; Sultana N; Sharkar MT; Noritake H; Kimura W; Wu YX; Kobayashi Y; Uezato T; Miura N
Biochem Biophys Res Commun; 2012 Jan; 417(1):601-6. PubMed ID: 22182413
[TBL] [Abstract][Full Text] [Related]
56. Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression.
Liu TM; Ng WM; Tan HS; Vinitha D; Yang Z; Fan JB; Zou Y; Hui JH; Lee EH; Lim B
Stem Cells Dev; 2013 Jan; 22(2):268-78. PubMed ID: 22765508
[TBL] [Abstract][Full Text] [Related]
57. CUL7 is a novel antiapoptotic oncogene.
Kim SS; Shago M; Kaustov L; Boutros PC; Clendening JW; Sheng Y; Trentin GA; Barsyte-Lovejoy D; Mao DY; Kay R; Jurisica I; Arrowsmith CH; Penn LZ
Cancer Res; 2007 Oct; 67(20):9616-22. PubMed ID: 17942889
[TBL] [Abstract][Full Text] [Related]
58. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
[TBL] [Abstract][Full Text] [Related]
59. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
60. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro.
Yang YK; Ogando CR; Wang See C; Chang TY; Barabino GA
Stem Cell Res Ther; 2018 May; 9(1):131. PubMed ID: 29751774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
